Potential treatment for Parkinson’s dementia
A potential drug treatment for Parkinson’s dementia called ENT-01 improved cognitive function in some trial participants. During the 10-week treatment period these participants had better mental abilities such as remembering and problem-solving, and these continued to improve during the six weeks following treatment. The charity Parkinson’s UK has invested £2 million in phase 2 of…